Post No. 2,553 The following is brought to you by Intellivest Securities Research, Inc. Toward the end of this Blog is a list of the Dow 30 current CEOs, and a recent ranking of the Dow 30 components by market capitalization as of January 27, 2014 and a summary of Dow 30 components' recent SEC filings as of January 27, 2014.
A read of the print editions of Tuesday's Wall St. Journal, Financial Times, Investor's Business Daily, New York Times, USA Today, Atlanta Journal Constitution & Daily Report (Ga. - carries Bloomberg) yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by a separate table of Dow component's symbol and Monday's closing stock prices and related data in alphabetical order.
The Dow Jones Industrial Average:The Dow Jones Industrial Average closed Monday at 15372.80 down 326.05 or 2.08% from Friday's close of 15698.85. For the year the Dow is down 7.26%. Of the Dow components only Pfizer gained and 29 declined. The only and therefore biggest gainer dollar-wise and percentage-wise was Pfizer up 20 cents or 0.66%. The biggest decliner dollar-wise was 3M down $.4.29 and percentage-wise was AT&T down 4.11 %.
Monday's Dow Jones Industrial Average closing numerator was 2393.79 down 50.66 from Friday's closing numerator of 2444.45. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor. Now, if you divide the Dow numerator change for today by the divisor (0.15571590501117) you get the change in today's Dow. A dollar increase or decrease in a Dow stock results in a $6.42 change in the Dow Index.
WSJ pA1 "Factory weakness hits stocks" by Dan Strumpf, Neil Shah says a round of weak manufacturing reports Mon reignited fears about the health of the US economy, fueling the sharpest one day decline in the Dow. Walmart is charted under Bad News as it reduced i8ts earnings estimate for 4Q. Pfizer was charted under Good News as it announced positive results from a trial of a treatment for breast cancer.
IBD pB2 "Leaders slammed again as correction intensifies" by Ken Shreve says the market correction gained steam Mon as major averages sold off again in higher vol. Current outlook is the market is in a correction.
FT p19 "Pfizer bucks declines as hopes rise of cancer blockbuster" by Eric Platt says shares in Pifzer rallied after a mid stage drug trial of an experimental breast cancer treatment met its goals of delaying the progression of symptoms in women with locally advanced or newly diagnosed metastatic cancer. Telecoms fell after AT&T said it would cut prices below Verizon's by $100 a month.
USAT p1A "Investors brace for bigger drop" by Adam Shell says the market has lost $1.2 trillion since start of the year and a correction is predicted.
NYT pB1 "As recovery looks weak, stocks take a deep dive" & AJC pA1 "Slow growth extends stock slide" by Nathaniel Popper, NYT says disappointing data on the US economy pushed Wall St on Mon to its worst day in an already bad year.
As of the open of the market on Tuesday the current divisor for the Dow Jones Industrial Average found at page C6 of Tuesday's Wall St. Journal is 0.15571590501117. Tuesday's trailing P/E ratio is 14.71 down from Monday's trailing P/E ratio of 15.09 (last year it was 15.25). Tuesday's P/E estimate is 14.15 unchanged from Monday's P/E estimate of 14.15 (year ago it was 12.54) and Tuesday's dividend yield is 2.51 up from Monday's dividend yield of 2.20 (last year it was 2.50). The Dow's all-time high was 16,576.66 on December 31, 2013. The 12 year low close for the Dow was on March 9, 2009 when it fell to 6,547.05.
The average closing price (the closing numerator divided by 30) of Monday's Dow Jones Industrial Average was $79.79 down $1.69 from Friday's average closing price of $81.48. The median closing price of Monday's Dow Jones Industrial Average was $73.88 (WMT/HD) down $1.89 from Friday's median closing price of $75.77 (WMT/HD). The lowest volume was Travelers and the highest volume was GE.
If Monday morning before the market opened you had purchased 100 shares of each of the Dow Jones Industrial Average 30 shares (assuming you could buy fractional shares and assuming no transaction costs or dividends) and sold at the close you would have lost $5,066 ($244,445 - $239,379).
2/3//14 Mon. 4:41 pm MarketWatch by Anora Mahmudova says US stocks market closed with sharp losses on Monday, after
a much weaker-than-expected reading on manufacturing data as well as
concerns over a slowdown in China, triggered the worst selloff in
several months.The S&P 500 and the Dow Jones Industrial Average ended the day with the steepest decline since June 20.U.S. manufacturers expanded in January
at the slowest rate in eight months as the pace of new orders sharply
decelerated, according to the closely followed ISM index. The Institute
for Supply Management index sank to 51.3% from 56.5% in December. That’s
the lowest level since last May. Economists surveyed by MarketWatch had
expected the index to drop to 56%.The S&P 500 index
SPX
-2.28%
closed down 40.70 points, or 2.3%, at 1,741.89, falling below the key
level resistance level of 1,775. Market technicians watch this level
closely, as closing below it would trigger heavy selling by algorithmic
programs, which comprise about 40% of the market.The Dow Jones Industrial Average
DJIA
-2.08%
dropped 326.05 points, or 2.1%, to 15,372.80, falling below its 200-day
moving average. The drop is the seventh triple-digit decline this year.The Nasdaq Composite
COMP
-2.61%
ended the day 106.92 points, or 2.6%, lower at 3,996.96, its worst
one-day drop since June 1, 2012. The Russell 2000
RUT
-3.21%
index of small-cap stocks finished the day 3.1% lower at 1,095.51 and
is down 7.3% from its peak. “The headline numbers from the ISM data were
much weaker than expected
and it would be interesting to see just how much of it is due to bad
weather,” said Quincy Krosby, market strategist at Prudential
Financial.“Investors will be watching the employment data on Friday very
keenly,
to see if there is a confirmation that we are somehow entering a soft
patch. As the Fed continues with the tapering, the markets once again
react to bad news negatively and are recalibrating valuations to
economic data and earnings,” Krosby said.The main indexes ended January
with the steepest losses in more than a
year, as disappointing data from China -- which triggered selloffs in
emerging-markets currencies over the past two weeks -- and worries over
deflation in the euro zone forced investors to flee equity markets and
seek safer assets.The implied volatility as measured by the CBOE Vix
index, which moves
inversely to the S&P 500, jumped 14.6% to 21.09, a level not
seen
since Dec. 28 2012, when the markets confronted the fiscal cliff.The 10-year Treasurys rallied,
pushing yields to a fresh three-month low. Yields fell 7 basis points
to 2.58%.Less-than-stellar earnings results did little to alleviate
fears among investors.In other corporate news, shares of Jos. A. Bank
Clothiers Inc.
JOSB
-5.03%
fell 5% after The Wall Street Journal reported Sunday
that the company is in talks to buy fellow apparel retailer Eddie
Bauer, citing sources. Jos. A. Bank and Men’s Wearhouse Inc.
MW
+8.42%
have been locked in a monthslong battle to buy each other out. Shares
in Men’s Wearhouse slid 7.8%.Herbalife Ltd.
HLF
-0.20%
saw a volatile trade after the company said
it plans to offer $1 billion of convertible notes and use the proceeds
to buy back shares. Shares closed 7.2% higher.Ford Motor Co.
F
+0.21%
shares fell 2.7% after the car maker reported a 7% drop in January sales. General Motors Co.
GM
+0.20%
reported that its U.S. sales in January fell 12%, more than expected by
analysts. The stock fell 2.3%.Pfizer Inc
PFE
+0.49%
shares pared earlier losses to gain 0.7%. The pharmaceutical giant said a trial for its advanced breast cancer treatment met its primary goal.In other markets, the Nikkei Stock Average
JP:NIK
-2.95%
fell 2.4%, putting it in a technical correction as it closed at 14,619.13, which is just 10% off from a Dec. 30 high of 16,291.European stocks
markets moved lower on Monday, mirroring a negative mood in Asia, after
Chinese manufacturing data added to fears about a slowdown in the
world’s second-largest economy.
Tuesday's Dow News followed by Monday's Closing Dow Numbers:
AT&T: FT p13 "AT&T reviews options closer to home" says AT&T in a conference call shocked investors by forecasting that high capial expenditure and Next, an installment plan to encourage users to buy smartphones, would dramatically hit free cash flow.
American Express: No mentions found.
Boeing: No mentions found.
Caterpillar: No mentions found.
Chevron: IBD pA2 "GE, Chevron form energy pact" says Chevron and GE will offer multiple downstream technologies and services.
Cisco: No mentions found.
Coke: AJC pA7 "Coca Cola catches heat, hurrahs for ad" by Christopher Seward says Coke's ad where America the Beautiful was sung in 7 language has become controversial.
Disney: WSJ pB6 "Disney to cut more staff at videogame div" by Ben Fritz says Disney's interactive media unit will lay off several hundred people despite a strong launch for its game Infinity. Disney Interactive has 3,000 employees.
DuPont: No mentions found.
Exxon: No mentions found.
GE: WSJ pA1 "Firms pinched by pressure to hold down their prices" by Theo Francis says execs from firms as varied as GE and others said some prices slipped in the last 3 months of year amid intense competition, weaker demand & pressure from cost conscious customers. McDonald's said in its 4Q falling prices resulted in a street fight for market share.
IBD pA2 "GE, Chevron form energy pact" says Chevron and GE will offer multiple downstream technologies and services.
Goldman Sachs: No mentions found.
Home Depot: No mentions found.
Intel: No mentions found.
IBM: No mentions found.
JPMorgan: No mentions found.
Johnson & Johnson: WSJ pA1 "Rivals band together in search for new drugs" by Monica Langley, Jonathan D. Rockoff says 10 big drug firms, including Johnson, & Johnson, Merck, & Pfizer have formed a 5 year collaboration to share scientists, tissue and blood samples & data.
McDonald's: WSJ pA1 "Firms pinched by pressure to hold down their prices" by Theo Francis says execs from firms as varied as GE and others said some prices slipped in the last 3 months of year amid intense competition, weaker demand & pressure from cost conscious customers. McDonald's said in its 4Q falling prices resulted in a street fight for market share.
Merck: WSJ pA1 "Rivals band together in search for new drugs" by Monica Langley, Jonathan D. Rockoff says 10 big drug firms, including Johnson, & Johnson, Merck, & Pfizer have formed a 5 year collaboration to share scientists, tissue and blood samples & data.
FT p19 "Reckitt Benckiser outperforms on MErck deal talk" says Reckitt may buy Merck Consumer Care that makes Coppertone and Claritin.
Microsoft: WSJ pB5 "NSA spying stymies US tech firms" by Michael Hickins says revelations about the NSA's eavesdrpopping have causing govs overseas to restrict US tech firms which will impact Google, Microsoft, Yahoo, LindIn and Facebook, among others.
IBD pB9 "Will new CEO lift Microsoft?" by Ken Hoove says Microsoft was a monster growth stock in the 90s as the world shifted to the PC but since 2000 the stock has gone nowhere.
Nike: No mentions found.
Pfizer: USAT p4B "Pfizer", IBD pA2 "Pfizer" say Pfizer was the only Dow gainer due to positive results from a study on its new breast cancer drug. The trial showed improvement in survival rates of postmenopausal women with certain breast cancers who took palbociclib with another drug, letrozole.
WSJ pA1 "Factory weakness hits stocks" by Dan Strumpf, Neil Shah says a round of weak manufacturing reports Mon reignited fears about the health of the US economy, fueling the sharpest one day decline in the Dow. Walmart is charted under Bad News as it reduced i8ts earnings estimate for 4Q. Pfizer was charted under Good News as it announced positive results from a trial of a treatment for breast cancer.
WSJ pA1 "Rivals band together in search for new drugs" by Monica Langley, Jonathan D. Rockoff says 10 big drug firms, including Johnson, & Johnson, Merck, & Pfizer have formed a 5 year collaboration to share scientists, tissue and blood samples & data.
FT p19 "Pfizer bucks declines as hopes rise of cancer blockbuster" by Eric Platt says shares in Pifzer rallied after a mid stage drug trial of an experimental breast cancer treatment met its goals of delaying the progression of symptoms in women with locally advanced or newly diagnosed metastatic cancer. Telecoms fell after AT&T said it would cut prices below Verizon's by $100 a month.
Procter & Gamble: No mentions found.
3M: No mentions found.
Travelers: No mentions found.
United Technologies: No mentions found.
UnitedHealth Group: No mentions found.
Verizon: No mentions found.
Visa: No mentions found.
Walmart: WSJ pA1 "Factory weakness hits stocks" by Dan Strumpf, Neil Shah says a round of weak manufacturing reports Mon reignited fears about the health of the US economy, fueling the sharpest one day decline in the Dow. Walmart is charted under Bad News as it reduced i8ts earnings estimate for 4Q. Pfizer was charted under Good News as it announced positive results from a trial of a treatment for breast cancer.
Tuesday's Dow News followed by Monday's Closing Dow Numbers:
AT&T: FT p13 "AT&T reviews options closer to home" says AT&T in a conference call shocked investors by forecasting that high capial expenditure and Next, an installment plan to encourage users to buy smartphones, would dramatically hit free cash flow.
American Express: No mentions found.
Boeing: No mentions found.
Caterpillar: No mentions found.
Chevron: IBD pA2 "GE, Chevron form energy pact" says Chevron and GE will offer multiple downstream technologies and services.
Cisco: No mentions found.
Coke: AJC pA7 "Coca Cola catches heat, hurrahs for ad" by Christopher Seward says Coke's ad where America the Beautiful was sung in 7 language has become controversial.
Disney: WSJ pB6 "Disney to cut more staff at videogame div" by Ben Fritz says Disney's interactive media unit will lay off several hundred people despite a strong launch for its game Infinity. Disney Interactive has 3,000 employees.
DuPont: No mentions found.
Exxon: No mentions found.
GE: WSJ pA1 "Firms pinched by pressure to hold down their prices" by Theo Francis says execs from firms as varied as GE and others said some prices slipped in the last 3 months of year amid intense competition, weaker demand & pressure from cost conscious customers. McDonald's said in its 4Q falling prices resulted in a street fight for market share.
IBD pA2 "GE, Chevron form energy pact" says Chevron and GE will offer multiple downstream technologies and services.
Goldman Sachs: No mentions found.
Home Depot: No mentions found.
Intel: No mentions found.
IBM: No mentions found.
JPMorgan: No mentions found.
Johnson & Johnson: WSJ pA1 "Rivals band together in search for new drugs" by Monica Langley, Jonathan D. Rockoff says 10 big drug firms, including Johnson, & Johnson, Merck, & Pfizer have formed a 5 year collaboration to share scientists, tissue and blood samples & data.
McDonald's: WSJ pA1 "Firms pinched by pressure to hold down their prices" by Theo Francis says execs from firms as varied as GE and others said some prices slipped in the last 3 months of year amid intense competition, weaker demand & pressure from cost conscious customers. McDonald's said in its 4Q falling prices resulted in a street fight for market share.
Merck: WSJ pA1 "Rivals band together in search for new drugs" by Monica Langley, Jonathan D. Rockoff says 10 big drug firms, including Johnson, & Johnson, Merck, & Pfizer have formed a 5 year collaboration to share scientists, tissue and blood samples & data.
FT p19 "Reckitt Benckiser outperforms on MErck deal talk" says Reckitt may buy Merck Consumer Care that makes Coppertone and Claritin.
Microsoft: WSJ pB5 "NSA spying stymies US tech firms" by Michael Hickins says revelations about the NSA's eavesdrpopping have causing govs overseas to restrict US tech firms which will impact Google, Microsoft, Yahoo, LindIn and Facebook, among others.
IBD pB9 "Will new CEO lift Microsoft?" by Ken Hoove says Microsoft was a monster growth stock in the 90s as the world shifted to the PC but since 2000 the stock has gone nowhere.
Nike: No mentions found.
Pfizer: USAT p4B "Pfizer", IBD pA2 "Pfizer" say Pfizer was the only Dow gainer due to positive results from a study on its new breast cancer drug. The trial showed improvement in survival rates of postmenopausal women with certain breast cancers who took palbociclib with another drug, letrozole.
WSJ pA1 "Factory weakness hits stocks" by Dan Strumpf, Neil Shah says a round of weak manufacturing reports Mon reignited fears about the health of the US economy, fueling the sharpest one day decline in the Dow. Walmart is charted under Bad News as it reduced i8ts earnings estimate for 4Q. Pfizer was charted under Good News as it announced positive results from a trial of a treatment for breast cancer.
WSJ pA1 "Rivals band together in search for new drugs" by Monica Langley, Jonathan D. Rockoff says 10 big drug firms, including Johnson, & Johnson, Merck, & Pfizer have formed a 5 year collaboration to share scientists, tissue and blood samples & data.
FT p19 "Pfizer bucks declines as hopes rise of cancer blockbuster" by Eric Platt says shares in Pifzer rallied after a mid stage drug trial of an experimental breast cancer treatment met its goals of delaying the progression of symptoms in women with locally advanced or newly diagnosed metastatic cancer. Telecoms fell after AT&T said it would cut prices below Verizon's by $100 a month.
Procter & Gamble: No mentions found.
3M: No mentions found.
Travelers: No mentions found.
United Technologies: No mentions found.
UnitedHealth Group: No mentions found.
Verizon: No mentions found.
Visa: No mentions found.
Walmart: WSJ pA1 "Factory weakness hits stocks" by Dan Strumpf, Neil Shah says a round of weak manufacturing reports Mon reignited fears about the health of the US economy, fueling the sharpest one day decline in the Dow. Walmart is charted under Bad News as it reduced i8ts earnings estimate for 4Q. Pfizer was charted under Good News as it announced positive results from a trial of a treatment for breast cancer.
Monday's Closing Dow Numbers:
| Symbol | Last Sale | Change | % Change | Share Volume | Market |
| T |  | NYSE | |||
| AXP | | NYSE | |||
| BA | | NYSE | |||
| CAT | | NYSE | |||
| CVX | | NYSE | |||
| CSCO | | NASDAQ-GS | |||
| KO | | NYSE | |||
| DIS | | NYSE | |||
| DD | | NYSE | |||
| XOM | | NYSE | |||
| GE | | NYSE | |||
| GS | | NYSE | |||
| HD | | NYSE | |||
| INTC | | NASDAQ-GS | |||
| IBM | | NYSE | |||
| JPM | | NYSE | |||
| JNJ | | NYSE | |||
| MCD | | NYSE | |||
| MRK | | NYSE | |||
| MSFT | | NASDAQ-GS | |||
| NKE | | NYSE | |||
| PFE |  | NYSE | |||
| PG | | NYSE | |||
| MMM | | NYSE | |||
| TRV | | NYSE | |||
| UTX | | NYSE | |||
| UNH | | NYSE | |||
| VZ | | DualListed | |||
| V | | NYSE | |||
| WMT | | NYSE |
*****************************
Here are the current CEOs of the Dow 30 Companies:
AT&T T Randall L. Stephenson (Dallas, TX)
American Express AXP Kenneth I. Chenault (NY, NY)
Boeing BA W. James McNerney, Jr. (Chicago, Ill)
Caterpillar CAT Douglas Oberhelman (Peoria, Ill.)
Chevron CVX John Watson (San Ramon, CA)
Cisco CSCO John Chambers (San Jose, CA)
Coca Cola KO Muhtar Kent (Atlanta, GA)
Disney DIS Robert Iger (Burbank, CA)
DuPont DD Ellen Kullman (Wilmington, DE)
ExxonMobil XOM Rex W. Tillerson (Irving, Tx)
GE Jeffrey R. Immelt (Fairfield, CT)
Goldman Sachs GS Lloyd Blankfein (NY, NY)
Home Depot HD Frank Blake (Atlanta, GA)
Intel INTC Brian Krzanich (Santa Clara, CA)
IBM Virginia M. Rometty (Armonk, NY)
JPMorgan Chase JPM Jamie Dimon (NY, NY)
Johnson & Johnson JNJ Alex Gorsky (New Brunswick, NJ)
McDonald's MCD Donald Thompson (Oak Brook, Ill)
Merck MRK Kenneth Frazier (Whitehouse Station, N.J.)
Microsoft MSFT Steve Ballmer (Redmond, WA) (to be succeeded by Satya Nadella)
Nike NK Mark Parker (Beaverton, OR)
Pfizer PFE Ian Read (NY, NY)
Procter & Gamble PG A. G. Lafley (Cincinnati, OH)
3M MMM Inge Thulin (St. Paul, MN)
Travelers TRV Jay S. Fishman (NY, NY)
UnitedHealthUNC Stephen Hemsley (Minnetonka, MN)
United Technologies UTX Louis Chenevert (Hartford, CT)
Verizon VZ Lowell McAdam (NY, NY)
Visa V Charles W. Scharf (Foster City, CA)
Wal-Mart WMT Mike Duke (to be replaced on Feb. 2014 by Doug McMillon) (Bentonville, ARK)
***************************
Here are the Dow Jones Industrial Average 30 as of 1/27/14 ranked in order of market capitalization in billions:
1. Exxon Mobil XOM $414.66
2. Microsoft MSFT 299.08
3. WalMart WMT 260.40
4. Johnson & Johnson JNJ 253.76
5. GE 253.64
6. Chevron CVX 239.93
7. JPMorgan Chase JPM 221.96
8. Procter & Gamble PG 213.30
9. IBM 193.17
10. Pfizer PFE 192.23
11. AT&T T 176.53
12. Coke KO 171.03
13. Merck MRK 153.49
14. Visa V 137.68
15. Verizon VZ 136.48
16. Disney DIS 126.96
17. Intel INTC 122.88
18. Cisco CSCO 117.63
19. Home Depot HD 111.17
20.United Technologies UTX 104.41
21. Boeing BA 103.22
22. McDonald's MCD 93.60
23. American Express AXP 92.06
24. 3M MMM 86.82
25. Goldman Sachs GS 75.51
26. UnitedHealth UNH 72.13
27.Nike NKE 63.67
28. Caterpillar CAT 58.09
29. DuPont DD 55.79
30. Travelers TRV 29.9632.20
****************************************
Here are the latest 8K, 10Q & 10K & Proxy & certain other SEC filings as of 1/27/14:
Symbol & Co. Name/Date of Filing/Form Filed/ Comments
AT&T T:
1/22/14 8K re: certain fin'l items for 4Q
12.18/13 8K re: sale of AT&T's incumbent local exchange opers in Ct. to Frontier Comm. for $ 2 bil
12/16/13 8K re: redemption of shares of Perpetual Cumulative Pref. Stock held by subsidiaries
12/12/13 8K re: amendments to '11 Incentive Plan re: triggers of benefit acclerations
12/11/13 8K re: amendment to $5 bil credit agreement
12/6/13 8K; 11/20/13 8K; 11/14/13 8K & 11/5/13 all re: the tender offer of $3.3 bil of Notes
11/27/13 8K re: sale of $1.6 bil of 2.37% Global Notes due '18
11/25/13 8K re: sale of $1.0 bil of 3.82% Global Notes due '20
11/13/13 8K re: sale of $2 bil Euros of Global Notes
11/1/13 10Q & 2 8Ks 10/23/13 re: results of 3Qtr ended 9/30/13
American Express AXP:
1/16/13 8K re: 4Q results
1/15/14 8K re: deling. & write-off states for 3 mos. through 12/31/13
12/24/13 8K re: settlement with bank regulators re: credit card add-on products
12/19/13 8K re: settlement of class action filed by US merchants
12/16/13 8K re: deling. & write-off states for 3 mos. through 11/30/13
11/15/13 8K re: delinq. & write-off stats for each of the 3 months ended 10/31/13
Boeing BA:
12/19/13 8K re: promotion of Dennis A. Muilenberg from CEO of Boeing Defense, Space & Security to COO of Boeing & promotion of Raymond L. Conner to Boeing Vice-Chair & CEO of Beoing Comm'l Airplanes & technical amendments to By-laws
12/16/13 8K re: increase in quarterly dividend and add'l $10 bil for stock repurchase program
10/31/13 8K re: $2.3 bil 364 day evolving credit agreement and a $2.3 bil 5 year revolving credit agreement
10/23/13 10Q & 10/23/13 8K re: 3 Qtr ended 9/30/13
Caterpillar CAT:
1/27/14 8K re: 4Q results 12/31/13
1/24/14 8K re: 3 mo. dealer stats thru 12/13
12/23/13 8K re: restructuring of Gosseliers, Belgium ops
12/19/13 8K re: 3 mo. dealer stats thru 11/13
12/11 8K re: mandatory retirement of David R. Goode, Charles D. Powell & Joshua I. Smith from Board & amendment to by-laws
11/20/13 8K re: supplemental info re: retail sales of machines & power systems
11/1/13 10Q & 10/23/13 2 8Ks re: quarter ended 9/30/13
10/22/13 8K re: retail sales of machinery
10/9/13 8K re: amendment to bylaws re: majority voting for uncontested election of directors
Chevron CVX:
1/9/14 8K re: interim update for 4Q
12/13/13 8K re: election of Jon M. Huntsman, Jr. to Board & amendment to By-laws
11/8/13 10Q & 11/1/13 8K re: 3 Qtr ended 9/30/13
10/9/13 8K re: interim update for 3Q
Cisco CSCO:
12/23/13 8K re: exec pre-arranged stock trading plans
12/4/13 8K re: pre-arranged stock trading plan for EVP & Chief Dev. Officer
11/22/13 10Q re: 1 Qtr ended 10/26/13
11/20/13 8K re: amendment of '05 Stock Incentive Plan
11/13/13 8K re: 1 Qtr results & $15 bil increase in share buyback program
Coke KO:
1/24/14 8K & 12/18/13 8K both re: departure of EVP & Pres. of Coca-Cola Americas Steven A. Cahillane
11/1/13 8K re: completion of public offering of $3.25 bil of notes
10/24/13 8K & 10/24/13 10Q re: qtr ended 9/27/13 & transfer of India & South West Asia units from Eurasia & Africa operating segment to Pacific operating segment
10/15/13 8K re: 3Q results
Disney DIS:
1/24/14 Def. Proxy (& Prelim 12/23/13) re: Annual Shareholders Mtg on 3/18/14 at 10 am Keller Aud., Portland, OR
12/23/13 8K re: election of Jack Dorsey to Board
12/9/13 8K re: Medium-Term Note Program
11/20/13 & 11/7/13 8K re: fiscal year ended 9/28/13
10/8/13 8K re: amendment to bylaws to eliminate paper share certificates
10/2/13 8K re: new employment contract for Alan N. Braverman EVP, GC & Sec'y for annual salary of $1.4 mil
DuPont DD:
11/6/13 8K and 10/25/13 8K re: separation of Performance Chemicals segment
10/22/13 10Q & 10/22/13 8K re: 3 Qtr ended 9/30/13
10/22/13 & 8K re: results for qtr ended 9/30/13
ExxonMobil XOM:
11/5/13 10Q & 10/31/13 8K re: 3 Qtr ended 9/30/13
GE:
1/17/14 8K re: 4Q results
11/15/13 8K re: IPO of 20% of N. American Retail Finance business
11/1/13 10Q re 3 Qtr ended 9/30/13
10/18/13 8K re: 3Qtr results
10/16/13 8K re: exercise by Berkshire Hathaway of warrants for 10.7 mil shares
Goldman Sachs GS:
1/16/14 8K re: 4Q & year end results for 12/31/13.
12/2/13 8K re: approval by regulators of '13 Capital Plan
11/29/13 8K re: $1 bil Flaoting Rate Notes due '23
11/15/13 8K re: $1 bil Floating rate Notes due '18
11/15/13 8K re: Moody's downgrade of Goldman debt
11/7/13 10Q for qtr ended 9/30/13
10/21/13 8K re: retirement of J. Michael Evans as Vice Chair/Head of Growth Markets
10/17/13 8K re: 3Q results
10/1/13 8K re: exercise by Berkshire Hathaway of warrants for 13,062,594 shares
Home Depot HD:
11/27/13 10Q & 11/19/13 8K re: quarter ended 11/3/13
9/20/13 8K re: election of Helena B. Boulkes to Board of Dirs.
9/10/13 8K re: closing of sale of $3.25 bil notes
Intel INTC:
1/16/14 8K re: results for 4Qtr & fiscal year ended 12/28/13
12/9/13 8K re: amdmt to '07 Annul Pref. Cash Bonus Plan for Exec Officers
11/22/13 8K re: Investor Meeting
10/28/13 10Q re: Qtr ended 9/28/13
10/23/13 8K re: departure of David Perlmutter, EVP & GM, Architecture Group
10/15/13 2 8Ks re: results for qtr ended 9/28/13
IBM:
1/23/14 8K re: sale of x86 server portfolio to Lenovo
1/22/14 8K re: 4Q earnibgs presentation
1/21/14 8K re: fin'l results for period ending 12/31/13
12/13/13 8K re: consulting contract with retiring Mark Loughridge, SVP
11/20/13 8K re: 750 mil Euro issuance of debt securities
11/7/13 8K re: retirement of Mark Laughridge, SVP & CFO, Finance & Enterprise Transformat'n
11/6/13 8K re: 2.5 bil Euro sale of debt securities
11/1/13 8K recommendation against mini-tender offer by third parties
JPMorganChase JPM:
1/24/14 8K re: grant of restricted stock units to CEO Jamie Dimon
1/22/14 8K re: issuance of fixed to floating rate non-cumulative preferred stock
1/14/14 2 8Ks re: 4Q results
1/7/14 8K re: settlement with various regulations relating to Madoff fraud
1/3/14 8K re: election of Michael A. Nead to Board
11/20/13 8K re: settlement by payment of $13 bil to settle with the President's Residential Mortgage Backed Securities (RMBS) Work Group of the Fin'l Fraud Enforcement Task Force
11/18/13 8K re: settlement by payment of $4.5 bil with 21 inst'l investors re: RMBS claims
11/1/13 10Q for quarter ended 9/30/13
Johnson & Johnson JNJ:
1/21/14 8K re: 4Q 7 fiscal year ended 12/29/13 results
1/17/14 8K re: sale to Carlyle Group of Ortho-Clinical Diagnostics unit
12/4/13 8K re: sale of $3.5 bil Floating Rate notes
11/19/13 8K re: settlement of $2.5 Bil for DePuy hip system claims
11/4/13 10Q for Qtr ended 9/29/13
McDonald's MCD:
1/23/14 8K re: 4Q & full year results for period ended 12/31/13
12/9/13 8K re: Nov. sales
11/14/13 8K re: sale of 3 mil shares of Ckommon Stock
11/14/13 8K re: Investor Release re: future growth
11/8/13 8K re: 10/13 sales
10/30/13 10Q for Qtr ended 9/30/13
10/21/13 8K re: 3Q results
Merck MRK:
11/7/13 10Q & 10/28/13 8K re: 3 Qtr ended 9/30/13
10/1/13 8K re: global restructuring program and lay-offs of 8,500 employees
Microsoft MSFT:
1/23/14 10Q & 1/23/14 8K re: 4Q ended 12/31/13
12/6/13 8K re: issuance ofover $5 bil of notes un Euros & US Dollars
11/26/13 8K re: restructuring to a devices & services company
11/20/13 8K re: voting results of '13 Annual Meeting of Sahreholders on 11/19/13
10/24/13 10Q & 10/24/13 8K re: Qtr ended 9/30/13
10/8/13; 10/7/13 & 10/3/13 Proxy Materials re: annual shareholders meeting on 11/19 in Bellevue, Washington
Nike NKE:
1/7/1410Q & 12/23/14 8K & 12/19/13 8K re: 4Q ended 11/30/13
10/7/13 10Q, 9/30/13 8K & 9/26/13 8K re: results for qtr ended 8/31/13
9/24/13 8K re: voting results of annual meeting of shareholders on 9/19/13
Pfizer PFE:
12/28/13 8K re: retirement of M. Anthony Burns from Board
12/19/13 8K re: amdmt of By-laws
12/17/13 8K re: promotion of Albert Bourla to Group VP, Vaccine, ONcology & Consumer Health instead of Amy Schulman who leaves Pfizer (she was GC) & promotion of Susan Silberman to Pres. & GM Global Vaccines
11/8/13 10Q & 10/29/13 8K re: 3 Qtr ended 9/29/13
Procter & Gamble PG:
1/24/14 10Q & 1/24/14 2 8Ks re: results for fiscal year ended 12/31/13
1/14/14 8K re: declaration of quarterly dividend
12/13/13 8K re: amdmt to Code of Regulations
11/5/13 8K re: close of sale of 750 mil Euros 2% Notes due '21
11/4/13 8K close of sale of $2 bil Notes
10/28/13 8K re: reorganizing of Global Business Unit into: Global Beauty, Global Health & Grooming, Blogal Fabric & Home Care, & amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; Global Baby, Feminine & amp; amp; Family Unit
10/25/13 10Q & 2 8Ks re: 1 Qtr ended 9/30/13
10/11/13 8K re: voting results of annual shareholders meeting 10/8/13
10/8/13 8K re: declaration of quarterly dividends
3M MMM:
12/17/13 8K re: declaration of dividend & update of its 5 year plan ('13 - '17)
11/19/13 3 8Ks re: pre-arranged stock trading plans for CEO and other execs
10/31/13 10Q & 10/24/13 8K re: 3 Qtr ended 10/24/13
Travelers TRV:
1/21/14 8K re: 4Q results ended 12/31/13
10/22/13 10Q & 10/22/13 8K re: results for qtr ended 9/30/13
United Technologies UTX:
1/22/14 8K re: 4Q results
12/13/13 8K re: amdmt to B-Laws re: forum to adjudicate certain disputes
10/25/13 10Q & 10/22/13 8K re: 3 Qtr ended 9/30/13
10/22/13 8K re: 3Q results
UnitedHealth Group UNH:
1/16/14 8K re: 4Q & full year results
1/3/14 8K re: presentation at Goldman Scahs Healthcare Conf.
12/2/13 8K re: Annual Investors Conference to be held 12/3 in NYC
11/7/13 10Q re: 3 Qtr ended 9/30/13
10/17/13 8K re: 3Q results
Verizon Communications Inc. VZ:
1/21/14 8K re: 4Q results
12/10/13 8K re: issuance of shares to purchase Vodafone's 45% interest in Verizon Wireless
12/10/13 Proxy re: Special Mtg of Shareholders re: Vodafone 1/28/14 10 am Westin Governor Morris, Morristown, NJ
11/7/13 8K re: election of Shellye Archambeau as Dir.
10/24/13 10Q for Qtr ended 9/30/13
10/17/13 8K re: 3Q results
10/8/13 Proxy; 10/8/13 S-8 & 10/3/13 8K re: approval by shareholders to buy Vodafone's 45% interest in Verizon Wireless, registration of shares to be issued to Vodafone, & $12 bil credit facility to fund the purchase
Visa V:
12/13/13 Proxy re: Annual Mtg of Stockhodlers 1/29/14 8:30 am Crowne Plaza, Foster City, CA
11/25/13 8K re: Gary P. Coughlan not running for re-election to Board
11/22/13 10 K & 10/30/13 8K re: FY 9/30/13
10/23/13 8K re: '14 Annual Meeting of Shareholders to be held 1/29/14
WalMart WMT:
12/10/13 8K re: promotion of David Cheesewright to Pres. & CEO Walmart Int'l
12/6/13 10Q & 11/14/13 8K re: 3 Qtr ended 10/31/13
11/28/13 8K re: repalcement of CEO Mike Duke with C. Douglas McMillon effective 2/1/13
11/22/13 8K re: election of Pamela C. Craig to Board
10/21/13 10Q for quarter ended 7/31/13
10/1/13 8K re: issuance of 1.95% Notes due 2018
THAT'S All.
No comments:
Post a Comment